HTL-Strefa

Based in Ozorków, Poland, HTL-Strefa S.A. is a world leading manufacturer of lancets for capillary blood sampling. The company operates two business lines: Safety Lancets, used to obtain capillary blood samples for various diagnostic purposes and Personal Lancets, used for self-blood glucose monitoring.

Location	RoW
Ind. Focus	Life Science
Stage	Large-cap buyout
Homepage	www.htl-strefa.pl

Funds
Name	Argentum Ownership	Date Entry	Date Exit
EQT V LP	0.82%	2009-11-30

HTL-Strefa deals

EQT V completes tender offer for HTL-Strefa

(2009-11-30)

More news HTL-Strefa

Latest PE Voice

Harald Mix on Nordic private equity

- 1/10/2012 10:10:00 AM

At the Argentum Conference in 2010, we asked Harald Mix, Managing Partner and Co-founder of Altor Equity Partners about the outlook for future returns in Nordic private equity.

More >>

Calendar

2012-02-16 in Bergen

Vestlandskonferansen

2012-02-27 in Berlin

SuperReturn International 2012

2012-03-05 in Copenhagen

Nordic Fundraising Summit

2012-03-14 in Geneva

EVCA Investors' Forum

2012-03-15 in La Clusaz

EVCA Networking Event 2012